Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Bayer plans to double the research staff...
SciClone Pharma of the US acquired Shanghai-based NovaMed...
China offers many different opportunities to global...
According to reports, China will invest $1.7 trillion...
Regeneron Pharma and Bayer have begun a...
China released its 12th Five-year Plan for Medical...
Bayer Healthcare’s long term sales...
OriGene Technologies, a US research tool maker, acquired...
Last week, Roche said it would...
Bayer HealthCare has extended its...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
